Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05641662

Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure

Led by Linkoeping University · Updated on 2026-03-10

750

Participants Needed

12

Research Sites

271 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life. Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months. Patients randomised to the Heart-eXg group will receive an exergame with feedback and tailoring to adapt the exergaming advice. Patients will also be able to play with a person in their own network.

CONDITIONS

Official Title

Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with symptomatic heart failure (NYHA II-IV) confirmed by a cardiologist, regardless of ejection fraction
  • Clinically stable condition
  • Physically inactive
  • Aged 18 years or older, no upper age limit
  • Able to speak and understand the language of the study country
  • Willing to use a smartphone for the study (smartphone can be provided if needed)
Not Eligible

You will not qualify if you...

  • Unable to use an exergame due to visual, hearing, or cognitive impairments
  • Unable to perform the 6-minute walk test
  • Unable or unwilling to wear an activity monitor
  • Currently participating in a rehabilitation program
  • Not willing to play an exergame
  • Having co-morbidities that prevent benefiting from this exercise (e.g., history of stroke, severe cognitive dysfunction, or life expectancy under 6 months)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

Universidade do Porto Faculdade de Medicina

Porto, Portugal

Actively Recruiting

2

P. J. Safarik University

Košice, Slovakia

Actively Recruiting

3

Germans Trias i Pujol Hospital

Barcelona, Spain

Actively Recruiting

4

Hospital de Bellvitge

Barcelona, Spain

Actively Recruiting

5

Hospital del Mar

Barcelona, Spain

Active, Not Recruiting

6

Xarxa Assistencial Universitaria

Manresa, Spain

Actively Recruiting

7

INCLIVA

Valencia, Spain

Actively Recruiting

8

Jönköping Hospital Rydhov

Jönköping, Sweden

Actively Recruiting

9

Kalmar Länssjukhuset

Kalmar, Sweden

Terminated

10

Linköping University Hospital

Linköping, Sweden

Actively Recruiting

11

Primary Health Care Centers Östergötland

Norrköping, Sweden, 60591

Actively Recruiting

12

Vrinnevisjukhuset

Norrköping, Sweden

Actively Recruiting

Loading map...

Research Team

T

Tiny Jaarsma, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here